sellWeak cluster of 810b5-1 plan
Le-Quoc Alexis sold $16M of DDOG
Chief Technology Officer at Datadog, Inc.. 127,105 shares at an average of $122.63, traded Nov 11, 2024, filed Nov 13, 2024.
Warning score
30Value
$16M
127,105 shares
Holdings after
336,165
-27% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001561550-24-000177, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 8, 2024 | JOther Class A Common Stockindirect: By Trust10b5-1 | +41 | $0.00 | $0 | 76 | Nov 13, 2024 |
| Nov 11, 2024 | CConversion Class A Common Stock10b5-1 | +85,637 | $0.31 | $26k | 421,802 | Nov 13, 2024 |
| Nov 11, 2024 | CConversion Class A Common Stock10b5-1 | +30,780 | $0.91 | $28k | 452,582 | Nov 13, 2024 |
| Nov 11, 2024 | CConversion Class A Common Stock10b5-1 | +10,688 | $10.74 | $115k | 463,270 | Nov 13, 2024 |
| Nov 11, 2024 | SOpen-market sale Class A Common Stock10b5-1 | -77,355 | $122.06 | $9.4M | 385,915 | Nov 13, 2024 |
| Nov 11, 2024 | SOpen-market sale Class A Common Stock10b5-1 | -30,919 | $122.91 | $3.8M | 354,996 | Nov 13, 2024 |
| Nov 11, 2024 | SOpen-market sale Class A Common Stock10b5-1 | -6,993 | $124.00 | $867k | 348,003 | Nov 13, 2024 |
| Nov 11, 2024 | SOpen-market sale Class A Common Stock10b5-1 | -11,838 | $124.82 | $1.5M | 336,165 | Nov 13, 2024 |
| Nov 11, 2024 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -150,240 | $0.00 | $0 | 1,051,680 | Nov 13, 2024 |
| Nov 11, 2024 | MOption exercise Class B Common Stockderivative10b5-1 | +150,240 | $0.00 | $0 | 1,946,892 | Nov 13, 2024 |
| Nov 11, 2024 | CConversion Class B Common Stockderivative10b5-1 | -85,637 | $0.00 | $0 | 1,861,255 | Nov 13, 2024 |
| Nov 11, 2024 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -54,000 | $0.00 | $0 | 594,000 | Nov 13, 2024 |
| Nov 11, 2024 | MOption exercise Class B Common Stockderivative10b5-1 | +54,000 | $0.00 | $0 | 1,915,255 | Nov 13, 2024 |
| Nov 11, 2024 | CConversion Class B Common Stockderivative10b5-1 | -30,780 | $0.00 | $0 | 1,884,475 | Nov 13, 2024 |
| Nov 11, 2024 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -18,750 | $0.00 | $0 | 656,250 | Nov 13, 2024 |
| Nov 11, 2024 | MOption exercise Class B Common Stockderivative10b5-1 | +18,750 | $0.00 | $0 | 1,903,225 | Nov 13, 2024 |
| Nov 11, 2024 | CConversion Class B Common Stockderivative10b5-1 | -10,688 | $0.00 | $0 | 1,892,537 | Nov 13, 2024 |
Related signals
Other insiders at Datadog, Inc. and this insider’s other filings.
| Score | Side | Company | Insider | Value | Shares | Filed |
|---|---|---|---|---|---|---|
| 45Moderate | sell 310b5-1 | DDOG Datadog, Inc. | Agarwal Amit President | $3.7M | 25,000 | |
| 45Moderate | sell 510b5-1 | DDOG Datadog, Inc. | Pomel Olivier Chief Executive Officer | $3.0M | 19,226 | |
| 35Weak | sell 810b5-1 | DDOG Datadog, Inc. | Shah Shardul director | $1.2M | 7,916 | |
| 45Moderate | sell 810b5-1 | DDOG Datadog, Inc. | Agarwal Amit President | $3.9M | 25,000 | |
| 35Weak | sell 810b5-1 | DDOG Datadog, Inc. | Walters Sean Michael Chief Revenue Officer | $1.2M | 7,836 | |
| 40Moderate | sell 810b5-1 | DDOG Datadog, Inc. | Pomel Olivier Chief Executive Officer | $29M | 178,723 | |
| 26Weak | sell 810b5-1 | DDOG Datadog, Inc. | Acocella Kerry General Counsel and Secretary | $393k | 2,488 | |
| 48Moderate | sell 9 | DDOG Datadog, Inc. | Acocella Kerry General Counsel and Secretary | $483k | 3,175 | |
| 60Notable | sell 9 | DDOG Datadog, Inc. | Agarwal Amit President | $1.7M | 11,387 | |
| 45Moderate | sell 910b5-1 | DDOG Datadog, Inc. | Blitzer Adam Chief Operating Officer | $3.6M | 23,248 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.